Bioequivalence Study of Eltrombopag Olamine Tablets in Healthy Subjects in the Fed State
Clinical trial NCT06768619 · COMPLETED
Trial details
- NCT number
- NCT06768619
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-20
- Primary completion
- 2023-04-27
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.